NeuralBase AI Ltd. Enhances Chatbot Platform with ChatGPT Integration

NeuralBase AI Ltd., operating under its enterprise brand BMP AI, has announced a significant advancement in the development of its intelligent chatbot platform by integrating...

Jul 18, 2025 | Press Release

GeoVax Advances Mpox Vaccine Development Amid Global Outbreak Concerns

The global health community faces a growing challenge as Mpox outbreaks, caused by both Clade I and Clade II strains, expand across continents. GeoVax Labs,...

Jul 18, 2025 | Press Release

Leading Health Experts Join American Heart Association Board to Combat Cardiovascular Diseases

The American Heart Association has announced the addition of two distinguished health professionals, Dr. Jennifer Ashton and Dr. Joseph Woo, to its Board of Directors....

Jul 18, 2025 | Press Release

Spring Hope Family Dentistry Offers Comprehensive Care for All Ages

Spring Hope Family Dentistry is setting a new standard for dental care in Spring Hope, NC, by offering comprehensive services designed to meet the needs...

Jul 18, 2025 | Press Release

Sekur Private Data Ltd. Adjusts Pricing Strategy in Response to Increased Cybersecurity Demand

Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a provider of Swiss-hosted cybersecurity and communication solutions, has announced an increase in pricing across...

Jul 18, 2025 | Press Release

Sekur Private Data Ltd. Adjusts Pricing Strategy in Response to Increased Cybersecurity Demand

Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a provider of Swiss-hosted cybersecurity and communication solutions, has announced an increase in pricing across...

Jul 18, 2025 | Press Release

Sekur Private Data Ltd. Adjusts Pricing Strategy in Response to Increased Cybersecurity Demand

Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a provider of Swiss-hosted cybersecurity and communication solutions, has announced an increase in pricing across...

Jul 18, 2025 | Press Release

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials

Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement with Sterling Pharma Solutions. This...

Jul 18, 2025 | Press Release

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials

Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement with Sterling Pharma Solutions. This...

Jul 18, 2025 | Press Release